Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
Heba Youssef, Clinical Nutrition Pharmacist at Helwan General Hospital, shared a post on LinkedIn:
“Heparin-Induced Thrombocytopenia (HIT): The Prothrombotic Emergency You Cannot Miss
Heparin saves lives in the ICU – but in some patients, it silently triggers a life-threatening clotting cascade. Missing HIT is not an option.
What Is HIT?
IgG antibodies form against PF4-heparin complexes, causing:
- Platelet activation and consumption
- Massive thrombin generation
- High risk of arterial AND venous thrombosis
Critical reminder: HIT is a PROTHROMBOTIC disorder – not a bleeding disorder.
When to Suspect HIT?
- Platelet fall greater than or equals to 50% from baseline within 5-10 days of heparin exposure
- New thrombosis, skin necrosis at injection sites, or acute systemic reaction after IV heparin bolus
Pearl: A normal platelet count does NOT exclude HIT if it has fallen greater than or equal to 50% from baseline.
Calculate the 4Ts Score First
- 0–3 equals Low probability
- 4–5 equals Intermediate probability
- 6–8 equals High probability
Score greater than or equal to 4? Stop ALL heparin immediately. Do NOT wait for lab confirmation.
Diagnostic Steps
- 4Ts Score
- PF4-Heparin Immunoassay (ELISA)
- Serotonin Release Assay (SRA) – Gold Standard
Management
Stop ALL heparin sources – UFH, LMWH, flushes, heparin-coated devices.
Start a Non-Heparin Anticoagulant:
- Critically ill: Argatroban or Bivalirudin
- Clinically stable: DOACs or Fondaparinux
DOACs in acute HIT: not yet universally approved – follow institutional protocols.
Never give Warfarin in acute HIT.
Avoid platelet transfusion unless life-threatening bleeding.
Duration of Therapy
- Isolated HIT: Until platelet recovery (approximately 4 weeks)
- HIT with Thrombosis: 3-6 months
Never Forget
- Platelet fall greater than or equal to50% matters more than the absolute count
- Untreated HIT – thrombosis in 30–50% of patients
- Always rule out: sepsis, DIC, CRRT, ECMO, drug-induced thrombocytopenia
- Never delay treatment while awaiting confirmatory testing”

Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital